Rocket to Resume Clinical Trial following FDA Hold Lift

Rocket to Resume Clinical Trial following FDA Hold Lift

The US FDA (Food and Drug Administration) has lifted their clinical hold on Rocket Pharmaceuticals for their experimental gene therapy program for the treatment of Danon disease. Following the decision, Rocket announced it will resume patient enrollment later this...